References
- Ang L., N.P. Brenwald, R.M. Walker, J. Andrews and A. Fraise. 2007. Carbapenem resistance in Bacteroides fragilis. J. Antimicrob. Chemother. 59: 1042–1044.
- Cantón R., M. Akova, Y. Carmeli, C.G. Giske, Y. Glupczynski, M. Gniadkowski, D.M. Livermore, V. Miriagou, T. Naas, G.M. Rossolini and others. 2012. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 18: 413–431.
- Dortet L., L. Poirel and P. Nordmann. 2012. Rapid detection of carbapenemase-producing Pseudomonas spp. J. Clin. Microbiol. 50: 3773–3776.
- Dortet L., L. Poirel, C. Errera and P. Nordmann. 2014. Carb Acineto NP test for rapid detection of carbapenemase-producing Acinetobacter spp. J. Clin. Microbiol. 52: 2359–2364.
- Edwards R. and P.N. Read. 2000. Expression of ther carbapenemase gene (cfiA) in Bacteroides fragilis. J. Antimicrob. Chemother. 46(6): 1009–1012.
- Eitel Z., J. Sóki, E. Urbán, E. Nagy and ESCMID Study Group on Anaerobic Infection. 2013. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries. Anaerobe. 21: 43–49.
- EUCAST (European Committee on Antimicrobial Susceptibility Testing). 2016. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0. http://www.eucast.org.
- Nagy E., E. Urbán and ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria. 2011. Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin. Microbiol. Infect. 17: 371–379.
- Nordmann P., M. Gniadkowski, C.G. Giske, L. Poirel, N. Woodford, V. Miriagou and European Network on Carbapenemases. 2012. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Infect. 18: 432–438.
- Nordmann P., L. Poirel and L. Dortet. 2012. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 18: 1503–1507.
- Poirel L., R.A. Bonnin and P. Nordmann. 2013. Rapid identification of antibiotic-resistant bacteria: how could new diagnostic tests halt potential endemics? Expert. Rev. Mol. Diagn. 13: 409–411.
- Sóki J., Z. Eitel, E. Urbán, E. Nagy and ESCMID Study Group on Anaerobic Infections. 2013. Molecular analysis of the carbapenem abnd metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. Int. J. Antimicrob. Agents 41:122–125.
- Sóki J., E. Urbán, I. Szöke, E. Fodor and E. Nagy. 2000. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. J. Med. Microbiol. 49: 427–430.
- Thompson J.S. and M.H. Malamy. 1990. Sequencing the gene for an imipenem-cefoxitin-hydrolyzing enzyme (CfiA) from Bacteroides fragilis TAL2480 reveals strong similarity between CfiA and Bacillus cereus β-Lactamase II. J. Bacteriol. 172: 2584–2593.
- Toprak N.U., O.D. Uzunkaya, J. Sóki and G. Soyletir. 2012. Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital. Anaerobe. 18: 169–171.
- Wayne, P.A.; Clinical and Laboratory Standards Institute. 2016. CLSI Guidelines: Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplements M100S.
- Wexler H.M. 2007. Bacteroides: the good, the bad, and the nittygritty. Clin. Microbiol. Rev. 20: 593–621.
- Zahar J.R., H. Farhat, E. Chachaty, P. Meshaka, S. Antoun and G. Nitenberg. 2005. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: a 6-year retrospective study. Clin. Microbiol. Infect. 11: 724–729.